文献速递神经肿瘤

内镜辅助经颅手术治疗岩斜区脑膜瘤:单中心经验

Endoscope-Assisted Transcranial Surgery for Petroclival Meningiomas: A Single-Centre Experience.
PubMed 文献 · World Neurosurg · 2025-09-27

本研究为单中心回顾性病例对照研究,纳入2018年1月至2024年6月共62例岩斜区脑膜瘤患者,其中18例接受内镜辅助经颅手术、44例接受经颅显微手术。内镜辅助组全切除率更高、术后住院时间更短、肿瘤进展或复发率更低;倾向性评分匹配后内镜辅助组全切除率仍更优。

要点

  • 内镜辅助经颅手术可提高岩斜区脑膜瘤的全切除率
  • 内镜辅助组术后住院时间更短、肿瘤进展或复发更少
  • 匹配后内镜辅助手术与更高全切除率相关,可作为首选治疗考虑

核心结论

  • 内镜辅助显微手术提高岩斜区脑膜瘤全切除率,提供良好视野与肿瘤显露,可考虑作为岩斜区脑膜瘤患者的一线治疗。

研究设计与样本

  • 单中心回顾性病例对照研究,分析2018年1月至2024年6月临床数据,共纳入62例岩斜区脑膜瘤患者,18例内镜辅助经颅手术、44例经颅显微手术,采用倾向性评分匹配校正组间差异。

主要发现

  • 内镜辅助组全切除率83.3% vs 52.3%(P=0.046),术后住院时间9.50天[8.00, 13.75] vs 13.00天[10.00, 17.25](P=0.023),肿瘤进展或复发0 vs 15.9%。
  • 倾向性评分匹配后,内镜辅助手术组全切除率优于显微手术组(比值比7.51[1.37, 41.10],95%CI 1.37-41.10,P=0.021)。

临床怎么用

  • 对岩斜区脑膜瘤患者,可优先考虑内镜辅助经颅显微手术以争取更高全切除率并缩短术后住院时间。

局限性

  • 为单中心回顾性研究,样本量较小(共62例),内镜辅助组仅18例,结论需更大队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The surgical management of petroclival meningioma (PCM) remains a challenge in neurosurgery. This study compared the outcomes of endoscope-assisted microsurgery and conventional microscopic approaches to evaluate the safety and efficacy of endoscope-assisted transcranial techniques for PCM treatment. METHODS: This retrospective case-control study was conducted at our hospital. Clinical data from January 2018 and June 2024 were retrospectively analyzed. The primary outcome was gross total resection (GTR) rate, and the secondary outcomes included patient status, tumor progression or recurrence. Propensity score matching (PSM) was used to account for group differences. RESULTS: We enrolled 62 patients; 18 underwent endoscope-assisted transcranial surgery and 44 underwent transcranial microscopic surgery. The endoscope-assisted transcranial microsurgery group exhibited a higher GTR rate, shorter postoperative hospital stay, and lower tumor progression or recurrence rates than the transcranial microscopic surgery group (GTR: 83.3% vs. 52.3%, P = 0.046); postoperative hospital stay duration: 9.50 days [8.00, 13.75] vs. 13.00 days [10.00, 17.25], P = 0.023; and lower tumor progression or recurrence: 0 vs. 15.9%). After PSM, the endoscope-assisted surgery group had a better GTR rate, compared with the microsurgery group (odds ratio: 7.51 [1.37, 41.10], 95% confidence interval: 1.37-41.10, P = 0.021). CONCLUSIONS: PCM remains a surgical challenge. Endoscope-assisted microsurgery provides an increased GTR rate, offering excellent visualization and access to tumors. Therefore, it may be recommended as a first-line treatment for patients with PCM.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ji X, Yang S, Zhou P, et al. Endoscope-Assisted Transcranial Surgery for Petroclival Meningiomas: A Single-Centre Experience. World Neurosurg. 2025. PMID: 41022310. doi:10.1016/j.wneu.2025.124516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。